Analysis of the DF508 mutation in a Brazilian cystic fibrosis population: comparison of pulmonary status of homozygotes with other patients

Analysis of the DF508 mutation in a Brazilian cystic fibrosis population: comparison of pulmonary status of homozygotes with other patients

Sixty-one cystic fibrosis patients admitted for check-up or antibiotic treatment were enrolled for genetic and clinical evaluation. Genetic analysis was performed on blood samples stored on neonatal screening cards using PCR techniques to determine the presence of <FONT FACE="Symbol">...

Full description

Bibliographic Details
Main Authors:	Maróstica P.J.C., Raskin S., Abreu-e-Silva F.A.
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 1998-01-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	cystic fibrosis <FONT FACE=Symbol>D</font>F508 gene mutation genotype phenotype
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000400009

Similar Items

p.F508del in a heterogeneous cystic fibrosis population from Minas Gerais, Brazil
by: P.V.T. Vidigal, et al.
Published: (2008-08-01)

Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic Fibrosis
by: Tabea Horn, et al.
Published: (2020-10-01)

Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patients
by: Karin Yaacoby-Bianu, et al.
Published: (2022-10-01)

Use of PCR for the determination of the frequency of the deltaF508 mutation in Brasilian cistic fibrosis patients
by: Antonio B. de Miranda, et al.
Published: (1993-06-01)

Phenotype and Genotype of Two Taiwanese Cystic Fibrosis Siblings and a Survey of Delta F508 in East Asians
by: Chao-Jen Lin, et al.
Published: (2008-12-01)

Frequency of the deltaF508 mutation in 108 cystic fibrosis patients in São Paulo: comparison with reported Brazilian data Freqüência da mutação deltaF508 em 108 pacientes com fibrose cística de São Paulo: comparação com dados de estudos brasileiros
by: Thelma Suely Okay, et al.
Published: (2005-04-01)

The Inhibition of the Membrane-Bound Transcription Factor Site-1 Protease (MBTP1) Alleviates the p.Phe508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Defects in Cystic Fibrosis Cells
by: Raphaël Santinelli, et al.
Published: (2024-01-01)

Bioreduction of substituted a-tetralones promoted by Daucus carota root
by: Helena M. C. Ferraz, et al.
Published: (2008-01-01)

Estudo ab-initio da a-alanina em meio aquoso
by: Sambrano Júlio Ricardo, et al.
Published: (1999-01-01)

Two Siblings Homozygous for F508del-CFTR Have Varied Disease Phenotypes and Protein Biomarkers
by: Zhihong Zhang, et al.
Published: (2021-03-01)

Common CFTR gene mutations in cystic fibrosis patients in Mazandaran province - Iran
by: Haleh Akhavan-Niaki (PhD), et al.
Published: (2008-10-01)

Genotype-Phenotype Correlation for Cystic Fibrosis According to Registry Center of Cystic Fibrosis
by: Mandana Rafeey, et al.
Published: (2020-01-01)

NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
by: Chiara Brandas, et al.
Published: (2021-09-01)

Pituitary glycoprotein hormone a-subunit secretion by cirrhotic patients
by: Oliveira M.C., et al.
Published: (1999-01-01)

Decoding F508del Misfolding in Cystic Fibrosis
by: Xiaodong Robert Wang, et al.
Published: (2014-05-01)

Síndrome de pseudo-Bartter como presentación de fibrosis quística con mutación DF508
by: María de Jesús Galaviz-Ballesteros, et al.
Published: (2016-09-01)

XV-2c and KM: 19 haplotype analysis in Chilean patients with cystic fibrosis and unknown CFTR gene mutations
by: GABRIELA M REPETTO, et al.
Published: (2007-01-01)

Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T – a case report
by: Matthias Welsner, et al.
Published: (2019-04-01)

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators
by: Danya Muilwijk, et al.
Published: (2021-12-01)

Frequency of F508del Variant in Patients with Cystic Fibrosis from Paraguay
by: Celeste Vega, et al.
Published: (2023-03-01)

A comprehensive overview of the cystic fibrosis on the island of São Miguel (Azores, Portugal)
by: Joana Rosa, et al.
Published: (2020-01-01)

Topical application of a melanotropin analogue to vulgar vitiligo dermo-epidermal minigrafts
by: A.M. Schwartzmann-Solon, et al.
Published: (1998-12-01)

Glycosylation and the cystic fibrosis transmembrane conductance regulator
by: Glick Mary Catherine, et al.
Published: (2001-08-01)

Cystic fibrosis from genotype to phenotype: review article
by: Mohammad Sadra Modaresi, et al.
Published: (2020-10-01)

Gastroduodenal resistance and neural mechanisms involved in saline flow decrease elicited by acute blood volume expansion in anesthetized rats
by: Graça J.R.V., et al.
Published: (1997-01-01)

A theoretical model of the tridimensional structure of Bacillus thuringiensis subsp. medellin Cry 11Bb toxin deduced by homology modelling
by: Pablo Gutierrez, et al.
Published: (2001-04-01)

Frequency of 8 CFTR gene mutations in cystic fibrosis patients in Minas Gerais, Brazil, diagnosed by neonatal screening
by: C. Perone, et al.
Published: (2010-02-01)

Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis
by: Sener Okur D, et al.
Published: (2019-03-01)

Elexacaftor Mediates the Rescue of F508del CFTR Functional Expression Interacting with MSD2
by: Roberta Bongiorno, et al.
Published: (2023-08-01)

B-cell infiltration and frequency of cytokine producing cells differ between localized and disseminated human cutaneous leishmaniases
by: MGS Vieira, et al.
Published: (2002-10-01)

Does plasma ANP participate in natriuresis induced by <FONT FACE=Symbol>a</font>-MSH?
by: D.L.W. Picanço-Diniz, et al.
Published: (1997-04-01)

Respiratory Syncytial Virus Infection Disrupts Monolayer Integrity and Function in Cystic Fibrosis Airway Cells
by: Wayne Sullender, et al.
Published: (2013-09-01)

Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation
by: Onofrio Laselva, et al.
Published: (2019-10-01)

The role of IL-12 in experimental Trypanosoma cruzi infection
by: J.S. Silva, et al.
Published: (1998-01-01)

Effect of the injection of an extract of Ascaris suum on macrophage activation during the early phase of Mycobacterium bovis BCG infection in C57Bl/6 mice
by: A.P. Ferreira, et al.
Published: (1999-11-01)

Cystic fibrosis drug ivacaftor stimulates CFTR channels at picomolar concentrations
by: László Csanády, et al.
Published: (2019-06-01)

Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry
by: Senay Rueda-Nieto, et al.
Published: (2022-06-01)

Ventilatory muscle strength in cystic fibrosis patients: a literature review
by: J.P. Heinzmann-Filho, et al.
Published: (2015-12-01)

Estimação de parâmetros genéticos em bovinos de corte utilizando os métodos de máxima verossimilhança restrita e <FONT FACE=Symbol>Â</FONT>
by: Marcelo Hessel Van Melis, et al.
Published: (2003-12-01)

YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1
by: Patrícia Barros, et al.
Published: (2023-06-01)